Immunological pathogenesis of membranous nephropathy: focus on PLA2R1 and its role

W Liu, C Gao, H Dai, Y Zheng, Z Dong, Y Gao… - Frontiers in …, 2019 - frontiersin.org
Membranous nephropathy (MN) is the major cause of nephrotic syndrome with special
pathological features, caused by the formation of immune complexes in the space between …

Idiopathic membranous nephropathy: glomerular pathological pattern caused by extrarenal immunity activity

W Liu, C Gao, Z Liu, H Dai, Z Feng, Z Dong… - Frontiers in …, 2020 - frontiersin.org
Idiopathic membranous nephropathy (IMN) is a pathological pattern of glomerular damage
caused by an autoimmune response. Immune complex deposition, thickness of glomerular …

A conceptual framework linking immunology, pathology, and clinical features in primary membranous nephropathy

GB Lerner, S Virmani, JM Henderson, JM Francis… - Kidney International, 2021 - Elsevier
Primary membranous nephropathy is a leading cause of adult nephrotic syndrome. The field
took a major step forward with the identification of phospholipase A2 receptor (PLA2R) as a …

Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1–associated membranous nephropathy

G Haddad, JM Lorenzen, H Ma… - The Journal of …, 2021 - Am Soc Clin Investig
Primary membranous nephropathy (pMN) is a leading cause of nephrotic syndrome in
adults. In most cases, this autoimmune kidney disease is associated with autoantibodies …

[HTML][HTML] The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery

AE van de Logt, M Fresquet, JF Wetzels, P Brenchley - Kidney international, 2019 - Elsevier
The discovery in 2009 of the M-type phospholipase A2 receptor (PLA2R) as the primary
target in membranous nephropathy (MN) greatly advanced basic and clinical research …

Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice

NM Tomas, S Dehde, C Meyer-Schwesinger… - Kidney international, 2023 - Elsevier
Antibody-mediated autoimmune pathologies like membranous nephropathy are difficult to
model, particularly in the absence of local target antigen expression in model organisms …

[HTML][HTML] Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1

W Schlumberger, N Hornig, S Lange, C Probst… - Autoimmunity …, 2014 - Elsevier
Membranous nephropathy (MN) accounts for most cases of the nephrotic syndrome in
adults. Recently, studies on the underlying pathomechanisms led to the identification of the …

Membranous nephropathy: new pathogenic mechanisms and their clinical implications

E Hoxha, L Reinhard, RAK Stahl - Nature Reviews Nephrology, 2022 - nature.com
Membranous nephropathy (MN) is characterized histomorphologically by the presence of
immune deposits in the subepithelial space of the glomerular filtration barrier; its clinical …

[HTML][HTML] A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathyámimics podocyte injury in patients

C Meyer-Schwesinger, NM Tomas, S Dehde, L Seifert… - Kidney International, 2020 - Elsevier
The phospholipase A2 receptor 1 (PLA2R1) is the major autoantigen in patients suffering
from membranous nephropathy. To date, the lack of endogenous glomerular expression of …

Anti-PLA2R antibodies as a prognostic factor in PLA2R-related membranous nephropathy

SA Timmermans, MA Abdul Hamid… - American journal of …, 2015 - karger.com
Background: The natural course of idiopathic membranous nephropathy (MN) varies, as it is
known through favorable outcomes in most patients. However, one third of patients with …